ADA 2024 Insights

 

ADA 2024 Insights
S

Type-2 Diabetic Medication Regimen in Treating Depression and Metabolic Dysfunction Associated Steatotic Liver Disease (MASLD) in Veterans Using PHQ-9 and FIB-4 Scores

By ADA 2024 Insights FEATURING Sabyasachi Sen
By ADA 2024 Insights FEATURING Sabyasachi Sen
128 views
July 19, 2024
Comments 0
Login to view comments. Click here to Login
Videos
12:21

Shining the Spotlight on Multiple Daily Insulin Therapy: Real-World …

ADA 2024 Insights

J. Macleod

209 views
22:44

Management of Diabetes Mellitus Post Liver Transplant

ADA 2024 Insights

P. Choksi

133 views
14:32

Advances in the Pathophysiology & Treatment for Youth-Onset Type 2 D…

ADA 2024 Insights

S. Chung

211 views
10:11

Type-2 Diabetic Medication Regimen in Treating Depression and Metabo…

ADA 2024 Insights

S. Sen

128 views
32:13

Targeting Mitochondria via Microbiota & Probiotics in Type 2 Diabetes

ADA 2024 Insights

N. Shulzhenko

163 views
17:55

Neighborhood Determinants of Health - Lessons Outside the United Sta…

ADA 2024 Insights

C. Perez-Ferrer

77 views
16:10

The Effect of Fenofibrate on Progression of Diabetic Retinopathy: th…

ADA 2024 Insights

D. Preiss

482 views
14:30

How Spatial Metabolomics Revolutionizes Our Understanding of Diabeti…

UT Health San Antonio School of Medicine

K. Sharma

223 views
08:46

FLOW Trial Results: GLPs, the Kidneys, and Even More to Come!!

Robert Busch

833 views
21:15

Cost-Effectiveness of Early-Stage Type 1 Diabetes Detection

University of Colorado Department of Medicine

R. Mcqueen

169 views